Choiril Hana M
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

PENGARUH PEMBERIAN AIR PERASAN KUBIS (Brasica Oleraceae var. Capitata L.) TERHADAP DAYA ANALGETIK JAMU PEGAL LINU PADA MENCIT JANTAN DENGAN METODE RANGSANG KIMIA Oktavianingtyas, Yetti; -, Sunyoto; Hana M, Choiril
MOTORIK Jurnal Ilmu Kesehatan (Journal of Health Science) Vol 1, No 1 (2006)
Publisher : STIKES Muhammadiyah Klaten

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Penelitian tentang pengaruh sayuran terhadap obat atau jamu yang diminum oleh manusia masih terbatas, salah satunya adalah kubis. Pengaruh konsumsi kubis dengan obat tradisional yaitu jamu pegal linu “PL” sebagai obat untuk menghilangkan lelah, pegal linu, nyeri otot, encok dan penambah tenaga baru belum banyak diketahui masyarakat. Penelitian lain menyebutkan bahwa kubis mengandung senyawa indol yang dapat menginduksi enzim biotranformasi sehingga dapat menurunkan daya anti inflamasi dari diklofenak. Penelitian ini untuk mengetahui pengaruh air perasan kubis apabila dikonsumsi secara bersamaan dengan jamu pegal linu sebagai penghilang rasa nyeri. Penelitian menggunakan uji acak lengkap pola searah, dengan 5 kelompok perlakuan dan masing-masing terdiri dari 8 ekor mencit putih jantan. Data yang diperoleh menunjukkan adanya penurunan jumlah geliat mencit pada tiap kelompok perlakuan bila dibandingkan dengan kontrol negatif (p<0.05), kemudian dihitung prosentase adanya analgetiknya. Daya analgetika jamu pegal linu “PL” 31,8% lebih rendah dibanding asam mefenamat 65,12%. Praperlakuan air perasan kubis dosis 25ml/kg BB 1 jam sebelum pemberian suspensi jamu pegal linu mampu menaikkan daya analgetik jamu pegal linu 41,28% (p<0.05), sedangkan perlakuan air perasan kubis dosis 25 ml/kg BB 1 kali sehari selama 3 hari sebelum pemberian suspensi jamu pegal linu tidak mempengaruhi daya analgetik jamu pegal linu “PL” 25,39%
FAKTOR YANG MEMPENGARUHI KEPATUHAN PENDERITA TBC UNTUK MINUM OBAT ANTI TUBERKULOSIS ( Factors contributing patiens’ compliance with Anti Tuberculostatic Drug Therapy) Lestari, Siti Lestari; Hana M, Choiril
MOTORIK Jurnal Ilmu Kesehatan (Journal of Health Science) Vol 1, No 2 (2006)
Publisher : STIKES Muhammadiyah Klaten

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

The overall aim of the study was to wxplore facilitating and obstructing factor for compliance with TB drug therapy. TBC is an infectious disease caused by mycobacterium Tuberculosis. It is still a health problem in the world, especially in development country. In Indonesia, there have been approximately 538.000 case per year of new active TBC with the mortality was 140.000. seventy five percent (75%) of the case suffered productive group (15 – 50 years old). Furthermore, TB is the third mortality after cardiovasculair and Upper Respiratory Infection ( Dep Kes RI, 2002). These statistic indicate that TB is still major health problem in Indonesia. Currently, management of TBC is conducted by all health care services including, public and private hospital, and community health center. The management of TB using Antituberculosa drug is provided by the Indonesia government. It is free and guarantee. The length of therapy needed is around 6-8 months, tend to cause patient’s uncomplaint, therefore leading to treatment failure and development of resistant strain. For this reason, it is important yo explore what factor contributing patient’s compliance for Tuberculostatic drug therapy. Data were collected by indepth interview from 10 respondents. A content analyses technique were used to analyses the data. The patient emphazed motivation for healing, support from family, and health education as facilitating factor. Other perceived promoting factors included supervision from Pengawas Minum Obat (PMO) and fear to spread the disease to their family. Examples of obstructing factors were the length of therapy and when they suffered from other disease. Key word : patient’s complain, Antituberculosis drug.